TEST:

TruSight Oncology Comprehensive

ALK (Anaplastic lymphoma kinase), APC (APC Regulator Of WNT Signaling Pathway), ATM (ATM serine/threonine kinase), ATRX (ATRX Chromatin Remodeler), BARD1 (BRCA1 Associated RING Domain 1), BCOR (BCL6 Corepressor), BRAF (B-raf proto-oncogene), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), BRIP1 (BRCA1 Interacting Protein C-terminal Helicase 1), CDK12 (Cyclin dependent kinase 12), CDK4 (Cyclin-dependent kinase 4), CHEK2 (Checkpoint kinase 2), CIC (Capicua Transcriptional Repressor), CTNNB1 (Catenin (cadherin-associated protein), beta 1), DNAJB1 (DnaJ Heat Shock Protein Family (Hsp40) Member B1), EGFR (Epidermal growth factor receptor), ER (Estrogen receptor), ERG (ETS Transcription Factor ERG), ETV1 (ETS Variant Transcription Factor 1), ETV6 (ETS Variant Transcription Factor 6), EWSR1 (EWS RNA Binding Protein 1), FANCL (FA Complementation Group L), FGFR2 (Fibroblast growth factor receptor 2), FGFR3 (Fibroblast growth factor receptor 3), FLI1 (Fli-1 Proto-Oncogene ETS Transcription Factor), FOXL2 (Forkhead Box L2), FOXO1 (Forkhead box O1), GLI1 (GLI Family Zinc Finger 1), H3F3A (H3 Histone Family Member 3A), HER-2 (Human epidermal growth factor receptor 2), HRAS (Harvey rat sarcoma viral oncogene homolog), IDH1 (Isocitrate dehydrogenase (NADP(+)) 1), IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2), KIT (KIT proto-oncogene, receptor tyrosine kinase), KRAS (KRAS proto-oncogene GTPase), MDM2 (E3 ubiquitin protein ligase), MET (MET proto-oncogene, receptor tyrosine kinase), MSI (Microsatellite instability), NCOA3 (Nuclear Receptor Coactivator 3), NRAS (Neuroblastoma RAS viral oncogene homolog), NTRK1 (Neurotrophic tyrosine kinase, receptor, type 1), NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2), NTRK3 (Neurotrophic tyrosine kinase, receptor, type 3), NUTM1 (NUT Midline Carcinoma Family Member 1), PALB2 (Partner and localizer of BRCA2), PAX3 (Paired Box 3), PDGFRA (Platelet Derived Growth Factor Receptor Alpha), PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PPP2R2A (Protein Phosphatase 2, Regulatory Subunit B, Alpha), PTCH1 (Patched 1), RAD51B (RAD51 Paralog B), RAD51C (RAD51 paralog C), RAD51D (RAD51 paralog D), RAD54L (DNA Repair And Recombination Protein RAD54), RANBP2 (RAN Binding Protein 2), RET (Ret Proto-Oncogene), ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS), SDHB (Succinate Dehydrogenase Complex Iron Sulfur Subunit B), SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A, member 4), TERT (Telomerase Reverse Transcriptase), TFE3 (Transcription Factor Binding To IGHM Enhancer 3), TMB (Tumor Mutational Burden), TP53 (Tumor protein P53), WT1 (WT1 Transcription Factor), YAP1 (Yes associated protein 1)